You are here

STTR Phase I: Localized Gene Delivery from Implantable Arterial Devices

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0711141
Agency Tracking Number: 0711141
Amount: $150,000.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: BT
Solicitation Number: NSF 06-598
Solicitation Year: 2006
Award Year: 2007
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
171 Main Street, Suite 302 6745 HOLLISTER AVENUE
Ashland, MA 01721
United States
DUNS: 131658739
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Matthew Phaneuf
 (508) 881-8860
Business Contact
 Matthew Phaneuf
Title: PhD
Phone: (508) 881-8860
Research Institution
 Beth Israel Deacness Medical Center
 Christine A Ferran
330 Brookline Ave
Boston, MA 2215
United States

 (508) 881-8860
 Nonprofit College or University

This Small Business Technology Transfer (STTR) Phase I research project aims to develop a fibrous material for the embedment and gradual release of appropriate genetic material, including small interfering RNA (siRNA), and viral vectors carrying genes for anti-inflammatory molecules, from coronary stents and prosthetic grafts. With over one million stents, and 70,000 prosthetic grafts placed each year, development of a reliable material that can release biological entities such as viral vectors and siRNA can be of large benefit for the millions of individuals suffering from heart disease and other occlusive ailments.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government